Opaleye Management Inc. 13D and 13G filings for Protara Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2020-09-25 5:20 pm Sale | 2020-09-24 | 13D | Protara Therapeutics, Inc. TARA | Opaleye Management Inc. | 2,508,472 23.860% | -2,527,538![]() (-50.19%) | Filing |